Treatments for recurrent soft tissue sarcoma
The following are treatment options for recurrent soft tissue sarcoma. Your healthcare team will suggest treatments based on your needs and your type of soft tissue sarcoma. They will work with you to develop a treatment plan. Treatments will depend on where the cancer comes back and the extent, or amount, of cancer in the body. Your healthcare team will also consider the type of treatment you had for the primary tumour.
Local recurrence means that the cancer comes back in the same area as the primary tumour. The following treatments may be offered for a local recurrence of soft tissue sarcoma.
Surgery is sometimes used to treat a local recurrence of soft tissue sarcoma. Surgery includes removing all of the tumour and some of the normal tissue around it.
Recurrences in a limb are often treated aggressively. The limb may need to be amputated, especially if limb-sparing surgery was used to treat the primary tumour.
External beam radiation therapy may be used after surgery to treat a local recurrence if it was not used to treat the primary tumour.
Distant recurrence, or metastatic cancer, means that the cancer comes back in a part of the body other than where the primary tumour developed. The following treatments may be offered for distant recurrent soft tissue sarcoma.
Chemotherapy may be offered when a soft tissue sarcoma recurs in distant organs, such as the lungs or liver.
Soft tissue sarcoma that recurs in a lung can sometimes be removed with surgery. This will depend on the number, size and location of the tumours in the lung.
External beam radiation therapy may be offered to relieve symptoms of advanced recurrent soft tissue sarcoma. This is called palliative radiation therapy.
You may be asked if you want to join a clinical trial for soft tissue sarcoma. Find out more about clinical trials.
Volunteering during Daffodil Month is an incredibly rewarding experience, whether you have been touched by cancer or not.
Great progress has been made
Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.